Navigation Links
TGen Drug Development partners with Horizon Discovery for integrated personalized medicine service
Date:4/12/2010

SCOTTSDALE, Ariz., and Cambridge, U.K. April 12, 2010 A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significant advance personalized medicine.

The partnership will create a beginning-to-end solution for pharmaceutical and biotechnology companies to more rationally design and tailor their drugs to specific patient populations based on the unique genetic variations that define a given disease.

TD2 will use Horizon's panel of more than 200 genetically-defined human isogenic cell-lines designed to accurately mirror cancer patient genetics in its comprehensive pre-clinical service as a prelude to performing selected in-house clinical trials. This will provide clients with a fully integrated drug discovery service that will accelerate the isolation and optimization of appropriately targeted therapeutic agents and attain their rapid market approval. And it will save time and money in the development of more effective cancer treatments.

"The future of oncology drug development will require us to predict which patients will respond to what drug," said Dr. Stephen Gately, TD2's President and Chief Scientific Officer, referring to the goal of personalized medicine treating patients with drugs tailor-made for their specific diseases.

"This partnership is the engine that will actually make this work and allow for the design of shorter and less-costly clinical trials that enroll the patients most likely to respond to a given drug," Gately said.

Today's agreement between TD2 and Horizon builds on another agreement announced Feb. 2 between Horizon and TD2's parent organization, the Translational Genomics Research Institute (TGen), to develop new human disease models for TGen's cancer research.

"Working with TD2 will enable us to broaden the impact of our GENESIS and X-MAN technologies in the quest for therapies that target the genetic causes of cancer in e
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Poverty Can Slow Kids Normal Development
2. SCDM to Showcase Professional Development Opportunities at Partnerships Event
3. Urine test for kidney cancer a step closer to development
4. Exposure to 3 classes of common chemicals may affect female development
5. RapidValue Launches iPad Application Development Services for Media & Publishing Firms
6. McMaster researcher leads development of promising drug for inflammation
7. Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases
8. Researchers discover fundamental step in immune-system development
9. EP Global Communications, Inc. Closes First Quarter With Positive Developments
10. Global Development Successes Depend on Access to Water
11. Gene is linked to lung cancer development in never-smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... filed on behalf of patients who allegedly developed Type ... forward in the federal multidistrict litigation now underway in ... LLP reports. According to court documents, the litigation will ... 10:00 a.m. The Court has directed Lead Counsel for ...
(Date:11/22/2014)... Forbes Living TV and ... announce that Ashley Lombardo and friend Candy Sherman are ... Ms. Lombardo entered friend Candy Sherman to receive a ... how her friend is courageously battling lung cancer and ... Despite medical bills piling up and the constant struggle ...
(Date:11/22/2014)... November 22, 2014 Developers and plugin specialist ... plugin entitled FCPX 3D Model bringing the impossible to ... allows users to add obj files to FCPX enabling 3d ... “Blurring the line between professional and armature, FCPX 3D Model ... Film Studios allows Final Cut Pro X users to upload ...
(Date:11/22/2014)... -- A clinical trial of hydroxyurea therapy for children ... early because the results show it is a safe ... the risk of stroke. The announcement about the ... the United States and Canada, was made this week ... (NHLBI). Researchers compared monthly blood transfusions with daily ...
(Date:11/22/2014)... -- The widely used heart drug digoxin is associated ... who have the heart rhythm disorder atrial fibrillation but ... Atrial fibrillation is a common form of irregular ... risk for stroke among older Americans. Digoxin has been ... irregular heartbeat, the authors of the new study said, ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3
... Research Hospital scientists have rewritten the job description of ... brain cells from DNA damage. Such damage might foreshadow ... in the developing brain require TopBP1 to prevent DNA ... to cell division. Investigators also reported that stem cells ...
... MONDAY, April 23 (HealthDay News) -- Hispanic people with lung ... with the disease, according to a new study. Researchers ... genetic factors or environmental advantages, such as lower rates of ... and survival data on cancer patients from a national database ...
... colleagues in China have described a rapidly emerging ... plays a pivotal role in establishing methicillin-resistant S. ... author Michael Otto, Ph.D., of NIH,s National Institute of ... the molecular level how MRSA epidemics may emerge and ...
... cent increase in high blood pressure screening in 19 developing countries ... that occur each year by up to 3 per cent in ... of Cardiology are the first findings from a new report from ... The study found that around 900 million people in developing countries ...
... Patients are much more likely to develop small-bowel obstruction after ... than minimally invasive laparoscopic surgery, a new study finds. ... can develop within days of surgery as a result of ... admission to a hospital. In this study, Swedish researchers ...
... new studies analyzing treatment decisions in late-stage amyotrophic lateral ... extend the duration and quality of life in this ... of Medicine at the University of Pennsylvania found that ... resulted in not living long enough to experience the ...
Cached Medicine News:Health News:Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor 2Health News:Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor 3Health News:Hispanics Seem to Have Better Odds of Lung Cancer Survival 2Health News:NIH scientists link quickly spreading gene to Asian MRSA epidemic 2Health News:Lower Risk for Bowel Obstruction With Less Invasive Surgery: Study 2Health News:ALS patients differ on treatment choices in later phases of disease 2
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
(Date:11/21/2014)... EVANSTON, Ill. , Nov. 21, 2014  Heated ... prescription drug prices – from cancer treatments to Gilead,s ... and pharmaceutical leaders around the world questioning what it ... quality of care. And while drug ... the pharmaceutical industry – from both a general business ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ... developer, manufacturer and seller of medicine and drugs ... announced that it plans to sell or transfer ... in the Chahaer Industrial Park, Inner Mongolia. Lotus, ...
... Inc. (OTC Bulletin Board: BHRT ) announced ... it finalized the formation of a working group. The ... clinical trial, combining a left ventricle assist device (LVAD) ... Bioheart,s MyoCath needle tipped catheter delivery system.   Initial ...
Cached Medicine Technology:Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 3Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 4Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: